Cited by 726Pancreatic function and diabetesMetabolism, Diabetes, and CancerAdipose Tissue and Metabolism

Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ

Open access
Garofalo, Robert S., Orena, Stephen J., Rafidi, Kristina, Torchia, Anthony J., Stock, Jeffrey L., Hildebrandt, Audrey L., Coskran, Timothy, Black, Shawn C. +4 more·2003·Journal of Clinical Investigation

Abstract

The serine/threonine kinase Akt/PKB plays key roles in the regulation of cell growth, survival, and metabolism. It remains unclear, however, whether the functions of individual Akt/PKB isoforms are distinct. To investigate the function of Akt2/PKBbeta, mice lacking this isoform were generated. Both male and female Akt2/PKBbeta-null mice exhibit mild growth deficiency and an age-dependent loss of adipose tissue or lipoatrophy, with all observed adipose depots dramatically reduced by 22 weeks of age. Akt2/PKBbeta-deficient mice are insulin resistant with elevated plasma triglycerides. In addition, Akt2/PKBbeta-deficient mice exhibit fed and fasting hyperglycemia, hyperinsulinemia, glucose intolerance, and impaired muscle glucose uptake. In males, insulin resistance progresses to a severe form of diabetes accompanied by pancreatic beta cell failure. In contrast, female Akt2/PKBbeta-deficient mice remain mildly hyperglycemic and hyperinsulinemic until at least one year of age. Thus, Akt2/PKBbeta-deficient mice exhibit growth deficiency similar to that reported previously for mice lacking Akt1/PKBalpha, indicating that both Akt2/PKBbeta and Akt1/PKBalpha participate in the regulation of growth. The marked hyperglycemia and loss of pancreatic beta cells and adipose tissue in Akt2/PKBbeta-deficient mice suggest that Akt2/PKBbeta plays critical roles in glucose metabolism and the development or maintenance of proper adipose tissue and islet mass for which other Akt/PKB isoforms are unable to fully compensate.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci16885

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 65 · Cited by 726

Research works printed but not linked: 1

  1. Kitamura, T., Nakae, J., Biggs, W.H., III, White, M.F., and Accili, D. 2001. The transcription factor FKHR promotes β cell survival in IRS-2 knock- out mice. International Symposium on Insulin Receptors and Insulin Action, 8th. Geneva, Switzerland. (Abstr.)

Authors
Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R., McNeish, J. D., & Coleman, K. G.
Affiliations
Pfizer (United States) (US)
Corresponding author
Garofalo, Robert S.
Venue
Journal of Clinical Investigation
Published
2003-07-15
Volume
112
Issue
2
Pages
197-208
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2148785089
Cited by
726
References
65
Citations by year
2026: 5 · 2025: 20 · 2024: 17 · 2023: 16 · 2022: 21 · 2021: 29 · 2020: 31 · 2019: 37 · 2018: 23 · 2017: 35 · 2016: 20 · 2015: 52 · 2014: 51 · 2013: 40 · 2012: 46
FWCI
28.20
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
lipoatrophy, adipose tissue loss, growth deficiency, insulin resistance, type 2 diabetes, pancreatic beta-cell failure, hyperglycemia, hyperinsulinemia, impaired glucose tolerance, muscle glucose uptake, plasma triglycerides, sex differences
MeSH terms
Adipose Tissue, Aging, Animals, Body Weight, Diabetes Mellitus, Experimental, Female, Genetic Vectors, Glucose, Glucose Tolerance Test, Glucose-6-Phosphatase, Glycogen Synthase, Hyperglycemia, Hyperinsulinism, Immunohistochemistry, Insulin, Islets of Langerhans, Liver, Male, Mice, Transgenic, Models, Genetic, Muscles, Organ Size, Phenotype, Phosphoenolpyruvate Carboxykinase (GTP), Proto-Oncogene Proteins, Time Factors, Tomography, X-Ray Computed, Polymerase Chain Reaction, Protein Serine-Threonine Kinases, Protein Isoforms, Caspases, Proto-Oncogene Proteins c-akt, Mice, Caspase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review